large-scale serologic testing program to assess the immunogenicity of inactivated hepatitis a vaccine (VAQTA) in prefilled syringes following product recall in Germany. [electronic resource]
- Human vaccines
- 233-6 p. digital
Publication Type: Journal Article
1554-8600
10.4161/hv.2.6.3492 doi
Germany Hepatitis A--prevention & control Hepatitis A Antibodies--blood Hepatitis A Vaccines--immunology Hepatitis A Virus, Human--immunology Humans Product Surveillance, Postmarketing Syringes Vaccines, Inactivated--immunology